GGrantIndex
Sort

23,748 grants matching melanoma

Targeting Checkpoint Inhibition in Anti-Tumor Responses

$97,500
Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2021 · CA

Targeting Checkpoint Inhibition in Anti-Tumor Responses

$97,500
Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2022 · CA

Identification and characterization of long noncoding RNAs in human melanomas

$97,500
Ranjan Joseph Perera · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2012 · CA

The role of miR-211 and its target genes in melanoma development in humans.

$97,500
Ranjan Joseph Perera · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2014 · CA

Reversal of T cell Exhaustion

$97,500
Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2016 · AI

Mayo Comprehensive Cancer Center Grant

$97,487
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2009 · CA

Career Development

$97,473
Dupont Guerry · Wistar Institute · P50 · FY2006 · CA

CORE--Pathology Core B: U. of PA consortium

$97,406
David E E Elder · Wistar Institute · P01 · FY2006 · CA

KLF4-mediated myeloid plasticity in breast cancer recurrence

$97,389
Walden Ai · Benedict College · SC3 · FY2021 · GM

KLF4-mediated myeloid plasticity in breast cancer recurrence

$97,389
Walden Ai · Benedict College · SC3 · FY2022 · GM

KLF4-mediated myeloid plasticity in breast cancer recurrence

$97,389
Walden Ai · Benedict College · SC3 · FY2023 · GM

KLF4-mediated myeloid plasticity in breast cancer recurrence

$97,389
Walden Ai · Benedict College · SC3 · FY2020 · GM

Targeting the Rac1 signaling pathway in malignant melanoma

$97,268
Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA

Investigation of the Wnt/PCP pathway in human malignant melanoma

$97,263
Andy J Chien · University Of Washington · K08 · FY2009 · CA

NADC Supplement

$97,249
Mohamed Abdel Mohsen · Wistar Institute · P30 · FY2020 · CA

BIOINFORMATICS

$97,235
Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2008 · CA

RhoC/GALR2 in the Metastasis of Oropharyngeal Cancers

$97,200
Bradley S Henson · University Of California Los Angeles · K08 · FY2006 · DE

Enhanced Development of the Xiphophorus Model System

$97,175
Ronald Walter · Texas State University · R24 · FY2018 · OD

Developmental Therapeutics Research Program

$97,006
Barbara Burtness · Yale University · P30 · FY2025 · CA

PEPTIDE MIMICS AND IMMUNOTHERAPY OF MELANOMA

$96,829
Roswell Park Cancer Institute Corp · R21 · FY2001 · CA

Neuro-Oncology Program

$96,814
Waldemar Debinski · Wake Forest University Health Sciences · P30 · FY2019 · CA

Clinical Cytophone platform for detection of circulating melanoma cells.

$96,800
James Suen · Cytoastra, Llc · R41 · FY2021 · CA

Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy

$96,797
Nicole E Scharping · University Of California, San Diego · K00 · FY2023 · CA

SPORE in Skin Cancer

$96,729
Meenhard Herlyn · Wistar Institute · P50 · FY2008 · CA

SPORE in Skin Cancer

$96,729
Meenhard Herlyn · Wistar Institute · P50 · FY2007 · CA